Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.35529 | 78 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.2875 | 77 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.06487 | 76 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.51144 | 78 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.2191 | 77 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.11422 | 77 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.11124 | 77 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.05237 | 76 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.27754 | 77 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.12468 | 76 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.60884 | 80 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.1898 | 76 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.10927 | 76 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.45055 | 79 |